Topic archive

university of miami

14 stories

9/14/2026

Psyence BioMed forms Texas entity for U.S. ibogaine research

Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.

9/10/2026

Filament Health begins stability testing for IBEX011, a botanical ibogaine drug.

9/10/2026

Filament Health begins stability program for IBEX011 amid rising ibogaine demand.

9/10/2026

IBEX011 stability program aims to meet growing demand for standardized ibogaine.

8/26/2026

The move promotes open science and could influence future psychedelic research.

8/21/2026

The move could expedite psychedelic research for veteran treatment.

8/21/2026

Trump administration accelerates psychedelic research for veterans' mental health.

8/19/2026

University of Miami's 1994 ibogaine application resurfaces, boosting market interest.

8/19/2026

Trump's administration advances psychedelic therapies for PTSD and TBI in veterans.

8/19/2026

U.S. federal actions could accelerate ibogaine's medical potential

8/19/2026

Company aligns with U.S. efforts to advance ibogaine research.

8/19/2026

Ibogaine, a psychedelic drug, gains federal attention for treating addiction.

8/19/2026

Trump announces transfer of ibogaine investigational drug application to accelerate research.

8/18/2026

The move aims to expedite ibogaine research under a new executive order.